1. The Value of Anti-angiogenics in Bladder Cancer Therapy
   Gerald Bastian Schulz et al, 2019, Tumor Angiogenesis CrossRef
2. Endothelin B Receptor, a New Target in Cancer Immune Therapy
   Lana E. Kandalaft et al, 2009, Clinical Cancer Research CrossRef
3. CD105-microvessel density analysis and its clinical value in urothelial carcinoma of bladder patients
   Rohit Siddhartha et al, 2024, Biomarkers CrossRef
4. Endothelin-1 Stimulates Lymphatic Endothelial Cells and Lymphatic Vessels to Grow and Invade
   Francesca Spinella et al, 2009, Cancer Research CrossRef
5. Endothelin-1 indicates unfavorable prognosis in primary high-grade non-muscle-invasive urothelial bladder cancer
   Lampros Mitrakas et al, 2021, Archivio Italiano di Urologia e Andrologia CrossRef
6. The Value of Anti-angiogenics in Bladder Cancer Therapy
   Gerald Bastian Schulz et al, 2017, Tumor Angiogenesis CrossRef